Phase I/IIa study of CNM-AgZn17.
Phase of Trial: Phase I/II
Latest Information Update: 06 Feb 2018
At a glance
- Drugs CNM AgZn17 (Primary)
- Indications Viral infections
- Focus Adverse reactions; Therapeutic Use
- 06 Feb 2018 New trial record
- 02 Feb 2018 According to the Clene Nanomedicine, this trial will commence by 2019.